Grifols To Divest Factor VIII Product Koate To Merge With Talecris
This article was originally published in The Pink Sheet Daily
Executive Summary
Italian company Kedrion will get the Factor VIII product Koate and a fractionation facility in Melville, N.Y., under a consent agreement with the Federal Trade Commission.